Skip to main content
. 2018 Apr 18;11(4):616–622. doi: 10.18240/ijo.2018.04.13

Table 5. Comparison of BCVA among nepafenac and ketorolac groups.

BCVA Nepafenac group (n=20) Ketorolac group(n=20) Test of significance
Preoperative 1.0 (0.6-1.5) 1.1 (0.6-1.5) Z=1.04; P=0.32
1wk postop. 0.3 (0.2-0.8) 0.3 (0.2-0.6) Z=1.05; P=0.29
1mo postop. 0.2 (0.0-0.6) 0.3 (0.0-0.6) Z=1.5; P=0.13
2mo postop. 0.0 (0.0-0.3) 0.25 (0.0-0.6) Z=1.92; P=0.055
3mo postop. 0.0 (0.0-0.2) 0.0 (0.0-0.3) Z=1.36; P=0.17

median (min-max), logMAR